1. Home
  2. NWGL vs AYTU Comparison

NWGL vs AYTU Comparison

Compare NWGL & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • AYTU
  • Stock Information
  • Founded
  • NWGL 2008
  • AYTU N/A
  • Country
  • NWGL Macau
  • AYTU United States
  • Employees
  • NWGL N/A
  • AYTU N/A
  • Industry
  • NWGL
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • AYTU Health Care
  • Exchange
  • NWGL Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • NWGL 20.0M
  • AYTU 19.7M
  • IPO Year
  • NWGL 2023
  • AYTU N/A
  • Fundamental
  • Price
  • NWGL $1.37
  • AYTU $1.71
  • Analyst Decision
  • NWGL
  • AYTU Strong Buy
  • Analyst Count
  • NWGL 0
  • AYTU 3
  • Target Price
  • NWGL N/A
  • AYTU $9.17
  • AVG Volume (30 Days)
  • NWGL 126.4K
  • AYTU 283.2K
  • Earning Date
  • NWGL 05-01-2025
  • AYTU 09-23-2025
  • Dividend Yield
  • NWGL N/A
  • AYTU N/A
  • EPS Growth
  • NWGL N/A
  • AYTU N/A
  • EPS
  • NWGL N/A
  • AYTU N/A
  • Revenue
  • NWGL $21,539,347.00
  • AYTU $66,382,000.00
  • Revenue This Year
  • NWGL N/A
  • AYTU $8.38
  • Revenue Next Year
  • NWGL N/A
  • AYTU $40.31
  • P/E Ratio
  • NWGL N/A
  • AYTU N/A
  • Revenue Growth
  • NWGL N/A
  • AYTU 1.84
  • 52 Week Low
  • NWGL $0.91
  • AYTU $0.95
  • 52 Week High
  • NWGL $6.61
  • AYTU $2.82
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 49.49
  • AYTU 25.29
  • Support Level
  • NWGL $1.35
  • AYTU $2.21
  • Resistance Level
  • NWGL $1.52
  • AYTU $2.66
  • Average True Range (ATR)
  • NWGL 0.12
  • AYTU 0.16
  • MACD
  • NWGL -0.01
  • AYTU -0.07
  • Stochastic Oscillator
  • NWGL 33.33
  • AYTU 5.93

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Share on Social Networks: